| NCT Number | NCT06216665 |
| Lead Sponsor | Pennington Biomedical Research Center |
| Conditions | Insulin Sensitivity |
| Enrollment | 12 participants |
| Start Date | 2024-03-04 |
| Primary Completion | 2025-12 (estimated) |
| Study Completion | 2025-12 (estimated) |
| Updated on ClinicalTrials.gov | 2025-01-16 |